Endoscopic Submucosal Dissection Market to Hit US$ 640.5 Million by 2034, Driven by GI Disease Surge & Tech Advancements

Companies in the Endoscopic Submucosal Dissection Market Must Foster Collaboration with Research Institutions, Healthcare Organizations to Drive Technological Innovation: Fact.MR Report

The global endoscopic submucosal dissection market is estimated at US$ 313 million in 2024, and it is projected to grow steadily with a 7.40% CAGR through 2034. The market is projected to surpass a valuation of US$ 640.5 million by 2034.

Developed and developing economies like the United States, China, and India are dealing with the rising number of cases associated with gastrointestinal diseases. This is generally due to the adoption of Westernized lifestyles that usually involve unhealthy eating habits, alcohol overuse, and sedentary living. Endoscopic submucosal dissection is one of the most effective and preferred treatments for gastrointestinal diseases, offering a minimally invasive approach that involves minimal to no pain in the treatment.

Endoscopic submucosal dissection (ESD) holds significant applications in the healthcare and medical sector, particularly in diagnosing and treating stomach cancer. Its significance in the medicare industry worldwide is touching the skies due to its role in removing early-stage gastrointestinal tumors. This procedure also allows for the precise and complete excision of abnormal growths in the mucosal layer of the digestive tract.

Technological advancements in endoscopic equipment have enhanced the safety and efficacy of ESD procedures, attracting more healthcare professionals to adopt this technique. The efficiency and accuracy of ESD technologies have made them one of the most reliable treatment options for both patients and surgeons. All these factors have collectively contributed to the exponential expansion of the ESD market, worldwide.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9328

Key Takeaways from the Market Study

• The global endoscopic submucosal dissection market is projected to expand at a CAGR of 7.40% for the forecast period of 2024 to 2034.
• The North American endoscopic submucosal dissection market is expected to grow at a remarkable CAGR of 8.90%for the forecast period of 2024 to 2034.
• The United States holds a dominant share of 88.40% of the endoscopic submucosal dissection market in the North American region.
• Japan dominates the global endoscopic submucosal dissection market, valued at US$ 85 million in 2024.
• The endoscopic submucosal dissection industry in the United States is expected to rise at a CAGR of 8.90%for the forecast period of 2024 to 2034.
• Based on the end-use, the hospitals segment held a 44.50% market share in 2024.
• The stomach cancer segment dominates the endoscopic submucosal dissection market with an 81.40% share in 2024, based on the indication.

“Companies involved in this market can develop and promote comprehensive education and training programs for healthcare professionals to ensure widespread adoption and proficiency in performing ESD procedures,"opines a Fact.MR analyst.

Competitive Landscape

Players such as Erbe Elektromedizin GmbH, Sumitomo Bakelite Co., Ltd., Ovesco Endoscopy AG, FUJIFILM Holdings Corporation, and Olympus Corporation hold significant market shares. These prominent companies have established substantial and loyal consumer bases consisting of hospitals, clinics, and laboratories globally.

Industry leaders play a pivotal role in driving innovation within the endoscopic submucosal dissection market. Their research and development efforts set industry standards, and smaller companies often rely on these innovations to meet regional demands.The market also comprises numerous smaller companies, primarily catering to regional entities. These companies face challenges related to limited financial resources for research and development.

Get Customization on this Report for Specific Research Solutions-
https://www.factmr.com/connectus/sample?flag=S&rep_id=9328

Endoscopic Submucosal Dissection Industry News:

1. Agilis Robotics Ltd. verified the viability and adaptability of its robotic equipment for endoscopic surgery on March 10, 2023, by completing its first test in mainland China. Surgeons successfully executed endoscopic submucosal dissection and en bloc resection of a bladder tumour during training simulations. At the Top of Form
2. Endoscopic submucosal dissection (ESD) services were introduced by Mediclinic Parkview Hospital on February 28, 2023, providing a less invasive option for patients who would have previously required surgical procedures like stomach, colon, or esophageal resection.
3. With the introduction of ClutchCutter and FushKnife during the 63rd Annual Conference of the Indian Society of Gastroenterology-ISGCON in Jaipur in January 2023, Fujifilm broadened its endoscopy offerings.

Key Segments Covered in Endoscopic Submucosal Dissection Industry

1. Endoscopic Submucosal Dissection Market by Product:
   1. Knives
   2. Tissue Retractors
   3. Grasp/Clips
   4. Injecting Agents
   5. Gastroscopes & Colonoscopes
2. Endoscopic Submucosal Dissection Market by Indication:
   1. Esophageal Cancer
   2. Stomach Cancer
   3. Colon Cancer
3. Endoscopic Submucosal Dissection Market by End User:
   1. Hospitals
   2. Ambulatory Surgical Centers
   3. Speciality Clinics
4. By Region:
   1. North America
   2. Latin America
   3. Europe
   4. Asia Pacific
   5. Middle East & Africa

Check out More Related Studies Published by Fact.MR:

The Americas hematology diagnostics market reached $264M in 2020 and is projected to grow at a 5% CAGR through 2031.

The endoscopy ultrasound market, valued at $997M in 2022, is expected to reach $1.85B by 2032, growing at a 5.7% CAGR.

The mobile imaging services market is set to rise from $1.8B in 2021 to over $2.7B by 2032, with a 3.9% CAGR.

The Laboratory Information Management System (LIMS) market held $1.8B in 2021 and is expected to grow at an 8.1% CAGR from 2022 to 2032.

The veterinary endoscopy market is forecasted to expand from $206.4M in 2024 to $386.7M by 2035, at a 5.9% CAGR.

The optical coherence tomography (OCT) for ophthalmology market, valued at $1.7B in 2022, is expected to surge at a 14.3% CAGR, reaching $6.5B by 2032.

The healthcare nanotechnology market is projected to grow from $7.05B in 2023 to $22.9B by 2033, at a 12.5% CAGR.

The dental adhesives market, valued at $2.86B in 2023, is expected to hit $5.89B by 2033, expanding at a 7.5% CAGR.